Woodcock Bemoans Lack Of 'Biobetter' Provision In BPCIA

 
• By Michael Cipriano
  
Woodcock_Janet_1200x675
CDER Director Janet Woodcock discussed the future of the US biosimilars market.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics